Announcement: Dimerix (ASX:DXB) has received Orphan Drug Designation in Japan for DMX-200
Автор: Dimerix
Загружено: 2025-09-29
Просмотров: 332
Описание:
Our lead asset DMX-200 has received Orphan Drug Designation in Japan for Focal Segmental Glomerulosclerosis (FSGS), adding to existing designations in the US and Europe. This milestone strengthens our global strategy to deliver one of the first approved therapies for #FSGS.
Discover more: https://investors.dimerix.com/investo...
-------------------------------------------
Website: https://dimerix.com
LinkedIn: / dimerix-bioscience
X/Twitter: https://x.com/dimerixltd
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: